C

Cellply

23 employees

Developing analytical systems to characterize next-generation cancer immunotherapy

Basic info

Industry

biotechnology research

Sectors

cell function
Biotechnology
potency
drug testing
Health Care
microsystems
cell therapy
immunotherapy
single-cell
Medical
cell analysis

Date founded

2013

Funding rounds raised

Total raised

$2.8M

from 9 investors over 9 rounds

C

Cellply raised $2.3M on December 15, 2021

Investors: Ashtree Global Management LLC, Metaventures, Italian Angels for Growth, Rearden Capital Management LLC, LIFTT and Indaco Venture Partners

C

Cellply raised $53K on December 1, 2016

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

C

Cellply raised $2.8M on March 20, 2014

Investors: Italian Angels for Growth and Indaco Venture Partners

FAQ